Chemed Co. (NYSE:CHE) Shares Bought by Cabot Wealth Management Inc.

Cabot Wealth Management Inc. grew its stake in Chemed Co. (NYSE:CHE) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,421 shares of the company’s stock after purchasing an additional 460 shares during the quarter. Chemed makes up approximately 1.6% of Cabot Wealth Management Inc.’s holdings, making the stock its 24th biggest holding. Cabot Wealth Management Inc. owned about 0.16% of Chemed worth $12,408,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Handelsbanken Fonder AB lifted its stake in Chemed by 2.6% during the fourth quarter. Handelsbanken Fonder AB now owns 3,972 shares of the company’s stock worth $2,104,000 after purchasing an additional 100 shares during the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Chemed in the 4th quarter worth about $2,540,000. Kestra Investment Management LLC boosted its holdings in shares of Chemed by 6.2% in the 4th quarter. Kestra Investment Management LLC now owns 1,060 shares of the company’s stock valued at $561,000 after buying an additional 62 shares during the period. Venturi Wealth Management LLC grew its position in shares of Chemed by 82.6% during the 4th quarter. Venturi Wealth Management LLC now owns 776 shares of the company’s stock valued at $411,000 after buying an additional 351 shares during the last quarter. Finally, CIBC Asset Management Inc raised its stake in Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after acquiring an additional 22 shares during the period. Institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CHE shares. Royal Bank of Canada decreased their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the transaction, the chief executive officer now owns 101,735 shares in the company, valued at approximately $58,270,755.95. The trade was a 1.93 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Brian C. Judkins purchased 145 shares of the stock in a transaction dated Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the acquisition, the vice president now directly owns 1,678 shares of the company’s stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Down 1.0 %

Shares of NYSE:CHE opened at $544.75 on Friday. The company’s 50-day moving average price is $542.60 and its 200 day moving average price is $563.71. The company has a market cap of $8.20 billion, a PE ratio of 27.53, a P/E/G ratio of 2.15 and a beta of 0.48. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $654.62.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.37%. Chemed’s dividend payout ratio is presently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.